The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS trial, the cardiovascular safety of interrupting beta-blocker could not be shown in comparison with beta-blocker continuation and beta-blocker interruption did not improve quality of life. ABYSS suggests that long-term beta-blocker therapy is recommended after an MI, even in the absence of heart failure, arrhythmia or uncontrolled hypertension.
You May Also Like
Fearful memories of others seen in mouse brain
17 de outubro de 2024
Study explores how traumatic brain injury (TBI) may be linked to Alzheimer’s disease
17 de outubro de 2024
More From Author
140 miles SE of Dutch Harbor, Alaska
17 de outubro de 2024
M 5.6 – Kermadec Islands region
17 de outubro de 2024
M 6.0 – 18 km W of Doğanyol, Turkey
17 de outubro de 2024